Kim Dong
SEC insider (Form 3/4/5 filer). CIK 0001920163. CFO at Tharimmune, Inc. (THAR) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 9, 2024. Located in PRINCETON, NJ.
Companies Kim Dong has filed insider reports for
- Tharimmune, Inc. (THAR): Officer, CFO
- UroGen Pharma Ltd. (URGN): Officer, Chief Financial Officer
Kim Dong
CIK: 0001920163
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (100.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
